BioVU

April 5, 2018

Nashville Biosciences created to leverage wealth of data

Officials with Vanderbilt University Medical Center announced the creation of a wholly owned subsidiary, Nashville Biosciences, to harness the power of its extensive genomic and bioinformatics resources to advance drug and diagnostics discovery and development.

By Bill Snyder
Illustration of human intestinal tract
March 22, 2018

Grant bolsters study of potential new therapy for C. diff infection

According to the Centers for Disease Control and Prevention, in 2011 in the United States there were almost half a million Clostridium difficile infections, and one in 11 patients 65 or older with a healthcare-associated C. diff infection died within 30 days of diagnosis.

By Paul Govern
Deciphering DNA code
March 15, 2018

Study spots undiagnosed genetic diseases in EHR

Patients diagnosed with heart failure, stroke, infertility and kidney failure could actually be suffering from rare and undiagnosed genetic diseases.

By Craig Boerner
February 26, 2018

Cannabis compound reduces seizures

Cannabidiol (CBD) oils reduced seizures in patients with difficult-to-treat epilepsy, Vanderbilt investigators have found.

By Leigh MacMillan
January 10, 2018

BioVU focus of Research Enterprise Forum Jan. 31

The School of Medicine will host a Research Enterprise Forum from 3 to 4 p.m. Wednesday, Jan. 31.

By VUMC News and Communications
autism concept: puzzle
November 16, 2017

Study may point to new treatment approach for ASD

Using sophisticated genome mining and gene manipulation techniques, researchers at Vanderbilt University Medical Center (VUMC) have solved a mystery that could lead to a new treatment approach for autism spectrum disorder (ASD).

By Bill Snyder
February 23, 2017

BioVU anniversary

Last week the BioVU Operations Oversight Board celebrated the 10-year anniversary of the launching of BioVU, Vanderbilt University Medical Center’s massive biobank.
By VUMC News and Communications
October 7, 2016

Rheumatoid subtypes explored by PheWAS

A computer-based method pioneered at Vanderbilt is being used to compare subtypes of rheumatoid arthritis.
By Paul Govern
July 7, 2016

VUMC chosen for leadership role in NIH Precision Medicine Initiative Cohort Program

Vanderbilt University Medical Center has been chosen by the National Institutes of Health to be a leader in a landmark study of genetic, environmental and lifestyle factors affecting the health of a million or more people. The NIH will provide $71.6 million over five years to VUMC, making this the largest research grant the Medical Center has ever received from any source.
By Bill Snyder
July 7, 2016

VUMC chosen for leadership role in NIH Precision Medicine Initiative Cohort Program

Vanderbilt University Medical Center (VUMC) has been chosen by the National Institutes of Health (NIH) to be the Data and Research Support Center for the Precision Medicine Initiative Cohort Program, a landmark study of genetic, environmental and lifestyle factors affecting the health of a million or more people, federal officials have announced.
By Bill Snyder
April 4, 2016

VUMC and Celgene Corporation enter into research agreement to accelerate development of next-generation therapeutics

Vanderbilt University Medical Center has entered into a strategic research agreement with Celgene Corporation, a biopharmaceutical company based in Summit, New Jersey.
By Bill Snyder
December 10, 2015

Genetics Institute director Cox set for next Discovery Lecture

Nancy Cox, Ph.D., founding director of the Vanderbilt Genetics Institute, will deliver the next Flexner Discovery Lecture on Thursday, Dec. 17.
By Leigh MacMillan
August 6, 2015

Genotyping project to be an ‘engine of discovery’

Vanderbilt University researchers next month will launch a major initiative to acquire “dense genotypes” from 100,000 individuals whose medical histories are known.
By Bill Snyder
1 … 4 5 6 7 8